Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2020

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2020

Summary

The publisher's Medical Devices sector report, “Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) uses an Implantable Cardioverter Defibrillator (ICD) to improve the coordination of the heart rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures
2.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Overview

3 Products under Development

3.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
3.2 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
3.3 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
3.4 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
3.5 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
3.6 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials

4 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products under Development by Companies

4.1 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development
4.2 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development

5 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies and Product Overview

5.1 Boston Scientific Corp Company Overview
5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 IRadimed Corp Company Overview
5.2.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Johns Hopkins University Company Overview
5.3.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.4 Mayo Clinic Company Overview
5.4.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.5 Medtronic Plc Company Overview
5.5.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.6 MicroPort CRM Company Overview
5.6.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
5.7 NewPace Ltd Company Overview
5.7.1 NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D)- Recent Developments

7 Appendix

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
Table 2: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
Table 3: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
Table 4: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
Table 5: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials
Table 7: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development
Table 8: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
Table 9: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

Figure 1: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
Figure 2: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
Figure 3: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
Figure 4: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
Figure 5: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
Figure 6: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials